Clinical trials
Terminated Esophageal Squamous Cell Carcinoma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 1 |
| 2008 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2017 | 3 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 2 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 26 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| National Cancer Institute (NCI) | 2 |
| Alliance for Clinical Trials in Oncology | 1 |
| Atreca, Inc. | 1 |
| Boston Scientific Corporation | 1 |
| Case Comprehensive Cancer Center | 1 |
| Eisai Inc. | 1 |
| GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. | 1 |
| Incyte Corporation | 1 |
| Medstar Health Research Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Esophageal Squamous Cell Carcinoma | 26 |
| Esophageal Neoplasms | 12 |
| Squamous Cell Carcinoma of Head and Neck | 8 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Melanoma | 5 |
| Carcinoma, Renal Cell | 4 |
| Carcinoma, Transitional Cell | 4 |
| Carcinoma, Hepatocellular | 3 |
| Colorectal Neoplasms | 3 |
| Neoplasm Metastasis | 3 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.